Cargando…

Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography

BACKGROUND: Contrast-induced nephropathy is acute kidney injury caused by contrast medium exposure. Serum creatinine is the clinical diagnostic standard, but it does not yield quick results. The serum level of cystatin C is stable and it can reflect renal function sensitively. The study aimed to ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mian, Zhang, Li, Yue, Rongzheng, You, Guiying, Zeng, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004983/ https://www.ncbi.nlm.nih.gov/pubmed/27548357 http://dx.doi.org/10.12659/MSM.897241

Ejemplares similares

Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography
por: Assareh, Ahmadreza, et al.
Publicado: (2016)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Preventive effect of reduced glutathione on contrast-induced nephropathy in elderly patients undergoing coronary angiography or intervention: a randomized, controlled trial
por: Jin, B., et al.
Publicado: (2015)

Use of Cystatin C and Serum Creatinine for the Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Contrast-Enhanced Computed Tomography at an Oncology Centre
por: Fortalesa Melo, Joao Italo, et al.
Publicado: (2015)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
por: Bidram, Peyman, et al.
Publicado: (2015)

Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial
por: Liu, Jinming, et al.
Publicado: (2016)

Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography
por: Lee, Ji Hwan, et al.
Publicado: (2017)

Elevation of preoperative cystatin C as an early predictor of contrast-induced nephropathy in patients receiving percutaneous coronary intervention
por: Gu, Guoqiang, et al.
Publicado: (2021)

Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization
por: Shukla, Anand N., et al.
Publicado: (2017)

Predictive value of post-procedural early (within 24 h) increase in cystatin C for contrast-induced acute kidney injury and mortality following coronary angiography or intervention
por: Liu, Yong, et al.
Publicado: (2017)

Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Zhu, Boqian, et al.
Publicado: (2016)

Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
por: Galal, Haitham, et al.
Publicado: (2020)

Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention
por: Barbieri, Lucia, et al.
Publicado: (2022)

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010)

Preventive Effect of Pretreatment with Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Angiography (PRINCIPLE Study)
por: Ko, Young-Guk, et al.
Publicado: (2013)

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review
por: Sacha, Jerzy, et al.
Publicado: (2019)

Impact of delayed hyperenhancement obtained by non-contrast computed tomography following coronary angiography in patients undergoing extracorporeal cardiopulmonary resuscitation
por: Watanabe, Tomomi, et al.
Publicado: (2020)

Furosemide with Saline Hydration for Prevention of Contrast-Induced Nephropathy in Patients undergoing Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials
por: Duan, Nana, et al.
Publicado: (2015)

The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis
por: Wu, Zhijun, et al.
Publicado: (2015)

Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Tang, Chengchun, et al.
Publicado: (2019)

Association between plasma endothelial microparticles and contrast-induced nephropathy in patients underwent coronary angiography
por: Fu, Xiaodan, et al.
Publicado: (2021)

Contrast-induced nephropathy following angiography and cardiac interventions
por: Rear, Roger, et al.
Publicado: (2016)

Allopurinol prophylactic therapy and the prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A prospective randomized controlled trial
por: Iranirad, Leili, et al.
Publicado: (2017)

Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA)
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2021)

Inflammatory biomarkers and risk of cardiovascular events in patients undergoing coronary angiography
por: Mohebi, Reza, et al.
Publicado: (2022)

Role of serum cystatin C in the prediction of contrast-induced nephropathy after intra-arterial interventions
por: Wang, Zheng-Yu, et al.
Publicado: (2020)

The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial
por: Gholoobi, Arash, et al.
Publicado: (2015)

Atorvastatin facilitates protection against contrast-induced nephropathy in patients undergoing coronary angiography via humoral mediators rather than altered renal hemodynamics
por: Wybraniec, Maciej T., et al.
Publicado: (2018)

The efficacy of remote ischemic conditioning in preventing contrast‐induced nephropathy among patients undergoing coronary angiography or intervention: An updated systematic review and meta‐analysis
por: Zhan, Biming, et al.
Publicado: (2019)

Brain natriuretic peptide as a biomarker for predicting contrast-induced nephropathy in patients undergoing coronary angiography/intervention: A systematic review and meta-analysis
por: Wu, Xuefeng, et al.
Publicado: (2022)

Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
por: Zhang, H., et al.
Publicado: (2021)

Short term high dose atorvastatin for the prevention of contrast-induced nephropathy in patients undergoing computed tomography angiography
por: Sanei, Hamid, et al.
Publicado: (2014)

NITRATE-CIN Study: Protocol of a Randomized (1:1) Single-Center, UK, Double-Blind Placebo-Controlled Trial Testing the Effect of Inorganic Nitrate on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography for Acute Coronary Syndromes
por: Beirne, Anne-Marie, et al.
Publicado: (2021)

Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2013)

Significance of serum FGF-23 for risk assessment of contrast-associated acute kidney injury and clinical outcomes in patients undergoing coronary angiography
por: Huang, Shao-Sung, et al.
Publicado: (2021)

Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions
por: Li, Wen-hua, et al.
Publicado: (2012)

Evaluation of Crocin Effect on Contrast-Induced Nephropathy Following Coronary Angiography or Angioplasty: A Randomized Controlled Trial
por: Shojaei, Lida, et al.
Publicado: (2022)

Predictive value of preprocedural albuminuria for contrast-induced nephropathy non-recovery in patients undergoing percutaneous coronary intervention
por: Chen, Hanchuan, et al.
Publicado: (2021)

The Effectiveness of Peer Group-Based Training on the Outcomes of Patients Undergoing Transradial Coronary Angiography
por: Dehghan, Ahmad Reza, et al.
Publicado: (2020)

Effect of kidney disease on all-cause and cardiovascular mortality in patients undergoing coronary angiography
por: Li, Qiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4o8bd8ul8mevvsteh9vgk2ifr6